Other Publications Referenced in Amarin’s Investor Communications ≪ Back to Publications To search publications using the available search words, please click here: Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap. Parhofer KG, Chapman MJ, Nordestgaard BG. Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap. Eur Heart J. 2020;22(Supplement J):J21-J33. https://doi.org/10.1093/eurheartj/suaa116 atherosclerosis cardiovascular risk dyslipidemia icosapent ethyl IPE REDUCE-IT trial
Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap. Parhofer KG, Chapman MJ, Nordestgaard BG. Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap. Eur Heart J. 2020;22(Supplement J):J21-J33. https://doi.org/10.1093/eurheartj/suaa116 atherosclerosis cardiovascular risk dyslipidemia icosapent ethyl IPE REDUCE-IT trial